Citigroup’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.31M Sell
146,525
-205,658
-58% -$1.84M ﹤0.01% 2346
2025
Q1
$2.64M Buy
352,183
+75,481
+27% +$566K ﹤0.01% 1863
2024
Q4
$2.08M Buy
276,702
+123,779
+81% +$931K ﹤0.01% 2104
2024
Q3
$1.16M Buy
152,923
+35,978
+31% +$273K ﹤0.01% 2449
2024
Q2
$723K Sell
116,945
-2,157,830
-95% -$13.3M ﹤0.01% 2461
2024
Q1
$11.6M Buy
2,274,775
+1,080,811
+91% +$5.49M 0.01% 835
2023
Q4
$7.15M Buy
1,193,964
+822,092
+221% +$4.92M 0.01% 965
2023
Q3
$2.63M Buy
371,872
+19,329
+5% +$137K ﹤0.01% 1334
2023
Q2
$2.48M Sell
352,543
-306,924
-47% -$2.16M ﹤0.01% 1523
2023
Q1
$5.5M Buy
659,467
+318,249
+93% +$2.65M ﹤0.01% 1082
2022
Q4
$3.92M Sell
341,218
-133,361
-28% -$1.53M ﹤0.01% 1160
2022
Q3
$5.98M Buy
474,579
+68,691
+17% +$866K ﹤0.01% 1037
2022
Q2
$4.29M Buy
405,888
+338,824
+505% +$3.58M ﹤0.01% 1189
2022
Q1
$1.09M Sell
67,064
-321,814
-83% -$5.24M ﹤0.01% 2265
2021
Q4
$5.39M Buy
388,878
+226,689
+140% +$3.14M ﹤0.01% 1239
2021
Q3
$2.33M Sell
162,189
-139,625
-46% -$2.01M ﹤0.01% 1795
2021
Q2
$4.77M Sell
301,814
-60,351
-17% -$954K ﹤0.01% 1449
2021
Q1
$3.68M Buy
362,165
+287,904
+388% +$2.93M ﹤0.01% 1547
2020
Q4
$554K Buy
74,261
+4,069
+6% +$30.4K ﹤0.01% 2567
2020
Q3
$242K Sell
70,192
-241,510
-77% -$833K ﹤0.01% 2684
2020
Q2
$1.49M Buy
311,702
+167,233
+116% +$797K ﹤0.01% 1830
2020
Q1
$288K Sell
144,469
-55,046
-28% -$110K ﹤0.01% 2633
2019
Q4
$688K Sell
199,515
-165,838
-45% -$572K ﹤0.01% 2440
2019
Q3
$1.05M Sell
365,353
-14,295
-4% -$41K ﹤0.01% 2086
2019
Q2
$1.44M Buy
379,648
+352,727
+1,310% +$1.34M ﹤0.01% 1874
2019
Q1
$219K Sell
26,921
-213,395
-89% -$1.74M ﹤0.01% 3066
2018
Q4
$1.94M Buy
240,316
+115,418
+92% +$932K ﹤0.01% 1556
2018
Q3
$953K Buy
124,898
+39,265
+46% +$300K ﹤0.01% 2040
2018
Q2
$491K Sell
85,633
-53,069
-38% -$304K ﹤0.01% 2370
2018
Q1
$662K Sell
138,702
-16,879
-11% -$80.6K ﹤0.01% 2116
2017
Q4
$764K Buy
155,581
+127,326
+451% +$625K ﹤0.01% 2057
2017
Q3
$148K Sell
28,255
-43,226
-60% -$226K ﹤0.01% 3132
2017
Q2
$398K Buy
71,481
+68,141
+2,040% +$379K ﹤0.01% 2558
2017
Q1
$28K Sell
3,340
-23,851
-88% -$200K ﹤0.01% 3941
2016
Q4
$172K Buy
27,191
+25,050
+1,170% +$158K ﹤0.01% 3652
2016
Q3
$10K Sell
2,141
-19,297
-90% -$90.1K ﹤0.01% 4435
2016
Q2
$61K Sell
21,438
-34,026
-61% -$96.8K ﹤0.01% 3594
2016
Q1
$157K Buy
55,464
+30,629
+123% +$86.7K ﹤0.01% 3662
2015
Q4
$257K Sell
24,835
-36,872
-60% -$382K ﹤0.01% 2867
2015
Q3
$703K Buy
61,707
+33,339
+118% +$380K ﹤0.01% 1966
2015
Q2
$423K Sell
28,368
-3,306
-10% -$49.3K ﹤0.01% 2259
2015
Q1
$286K Sell
31,674
-235
-0.7% -$2.12K ﹤0.01% 2669
2014
Q4
$389K Buy
31,909
+24,910
+356% +$304K ﹤0.01% 2647
2014
Q3
$68K Sell
6,999
-1,975
-22% -$19.2K ﹤0.01% 3443
2014
Q2
$115K Buy
8,974
+371
+4% +$4.75K ﹤0.01% 2988
2014
Q1
$91K Buy
8,603
+2,035
+31% +$21.5K ﹤0.01% 3563
2013
Q4
$50K Buy
6,568
+4,527
+222% +$34.5K ﹤0.01% 4160
2013
Q3
$15K Sell
2,041
-149
-7% -$1.1K ﹤0.01% 4406
2013
Q2
$3K Buy
+2,190
New +$3K ﹤0.01% 4795